Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1103920080140040519
Korean Journal of Hepatology
2008 Volume.14 No. 4 p.519 ~ p.524
Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation
Kim Byung-Kook

Kwon So-Young
Lee Chang-Hong
Han Hye-Seung
Chang Seong-Hwan
Ko Soon-Young
Choe Won-Hyeok
Abstract
Fibrosing cholestatic hepatitis (FCH) is the most devastating manifestation of recurrent hepatitis C in transplant recipients with hepatitis C virus (HCV), possibly leading to death or retransplantation. Although FCH was first described as a complication of hepatitis B, this manifestation has been well documented in association with HCV in the setting of liver transplantation, bone marrow transplantation, heart transplantation, and end-stage human immunodeficiency virus infection. We report the clinical course and antiviral response in a patient with FCH due to recurrent hepatitis C after cadaveric liver transplantation who was treated with pegylated interferon ¥á-2a and ribavirin.
KEYWORD
Hepatitis C, Liver Transplantation, Cholestasis, Fibrosis
FullTexts / Linksout information
  
Listed journal information
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø